Primary Recipient

PROGENICS PHARMACEUTICALS, INC.

Amount

$4,143,652.00

Award Date

9/29/2010

Administering Agency

Health and Human Services, Department of / National Institutes of Health

CDFA Number

93.701

CDFA Program Title

Trans-NIH Recovery Act Research Support

Description

Award Title:-? Novel, Non-antibiotic Therapy for Clostridium difficile-Associated Disease Award Description: Clostridium difficile is a spore-forming bacterium that is the leading cause of hospital acquired diarrhea and is responsible for more deaths per

Vendors Connected to Award

Vendor	Role	Amount
TRUSTEES OF TUFTS COLLEGE INC	Primary vendor	$170,306.00
BOARD OF REGENTS OF THE UNIVERSITY OF WISCONS	Primary vendor	$68,491.00
Ricerca Biosciences, LLC	Primary vendor	$79,650.00